BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Pappas Capital Announces the Passing of Senior Venture Partner Dr. Ernest Mario
News | 10. 21. 2024
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 -- It is with deep sadness that Pappas Capital announces the passing of Dr. Ernest Mario, Senior Venture Partner and one of the founders of Pappas’ venture capital business. Ernie joined Pappas Capital in 2002 as a member of the firm’s Scientific Advisory Board, becoming a Senior Venture Partner in 2011. He helped to build Pappas Capital into a leading life science venture capital firm and was a friend and mentor to the entire Pappas team. His counsel and legacy will always remain with us.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.